when were glp-1 agonists approved for weight loss Comparing GLP-type therapies in those without diabetes. Two glucagon-like peptide-1 receptor (GLP-1 RAs) (#semaglutide and #liraglutide) and one dual agonist (#tirzepatide) have been FDA-approved for #weightloss in adults GLP-1 Medications: Everything You Need

If youve already reached your desired weight and youre ready to move forward with breast implant surgery, weve got you covered there, too

Amino Acids Lower levels of amino acids such as asparagine, glutamine, serine, valine, citrulline, and arginine significantly impacted thyroid function by altering levels of thyroid hormones and TSH

Vimergy Zinc supports a healthy metabolism and immune system

Key supporting research from 2024-2025 includes a July 2024 paper in Inflammopharmacology (PMID: 38980576) linking BPC-157 to stress response mechanisms, a January 2025 HSS Journal systematic review on neuromuscular applications (PMID: 40756949), and a 2025 Journal of Neuropsychiatry and Clinical Neurosciences perspectives paper positioning BPC-157 as an emerging therapeutic for CNS disorders

The reduced production of pro-inflammatory cytokines with THC administration may occur through the inhibition of NF-B signaling in microglia and astrocytes, as observed in cell culture experiments (Kozela et al., 2010